Odaily Planet Daily reports: 10x Research posted on X that its quantitative model has generated its strongest altcoin buy signal since October 2025, with Bittensor (TAO) showing particularly strong performance; its price has now risen above both the 7-day and 30-day moving averages, posting a gain of approximately 38.6% in just one week. Analysts attribute part of this rally to news that NVIDIA plans to launch its open-source autonomous AI agent platform, NemoClaw, alongside further market sentiment support from General Tensor, an AI computing network ecosystem company, which recently completed a $5 million funding round. Bittensor’s network has recently transitioned to a Nominated Proof of Stake (NPoS) mechanism, which is expected to enhance network operational efficiency. As institutional capital increasingly focuses on exposure to “productive” AI infrastructure, trading volumes for AI-related tokens have risen significantly.
10x Research: Strongest Altcoin Buy Signal Since October 2025, AI Sector Gains Momentum
KuCoinFlashShare
Summary
Altcoin news reveals a major shift as 10x Research reports the strongest altcoin market buy signal since October 2025. Bittensor (TAO) leads with a 38.6% weekly gain, trading above key moving averages. The AI sector is gaining momentum, driven by NVIDIA’s NemoClaw and General Tensor’s $5 million funding round. Bittensor’s Nominated Proof of Stake upgrade and growing institutional interest in AI infrastructure are fueling altcoin market momentum.
Source:Show original
Disclaimer: The information on this page may have been obtained from third parties and does not necessarily reflect the views or opinions of KuCoin. This content is provided for general informational purposes only, without any representation or warranty of any kind, nor shall it be construed as financial or investment advice. KuCoin shall not be liable for any errors or omissions, or for any outcomes resulting from the use of this information.
Investments in digital assets can be risky. Please carefully evaluate the risks of a product and your risk tolerance based on your own financial circumstances. For more information, please refer to our Terms of Use and Risk Disclosure.